Reducing cardiovascular disease risk in patients with type 2 diabetes: A message from the national diabetes education program

被引:0
|
作者
Gavin, JR
Peterson, K
Warren-Boulton, E
机构
[1] Univ Minnesota, Sch Med, Dept Family Practice & Community Hlth, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[3] Hager Sharp Inc, Washington, DC USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Cardiovascular disease is responsible for 65 percent of deaths in persons with type 2 diabetes. However, awareness of cardiovascular disease risk factors among patients with diabetes remains low, resulting in missed opportunities to lower risks for coronary events and strokes. The National Diabetes Education Program has begun a campaign to increase patient participation in risk-reduction practice s by promoting the "ABCs" of diabetes care: A,c level, Blood pressure, and Cholesterol level. By increasing patient awareness of the link between diabetes and heart disease, family physicians can encourage patients to take medications (including aspirin), stop smoking, lower blood pressure, and lower cholesterol and blood glucose levels,. Copyright (C) 2003 American Academy of Family Physicians.
引用
收藏
页码:1569 / 1574
页数:6
相关论文
共 50 条
  • [31] Obesity and cardiovascular risk factors in type 2 diabetes:: results from the Swedish National Diabetes Register
    Ridderstråle, M
    Gudbjörnsdottir, S
    Eliasson, B
    Nilsson, PM
    Cederholm, J
    [J]. JOURNAL OF INTERNAL MEDICINE, 2006, 259 (03) : 314 - 322
  • [32] Promoting early diagnosis and treatment of type 2 diabetes - The National Diabetes Education Program
    Clark, CM
    Fradkin, JE
    Hiss, RG
    Lorenz, RA
    Vinicor, F
    Warren-Boulton, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (03): : 363 - 365
  • [33] The triglycerides-to-HDL-cholesterol ratio and cardiovascular disease risk in obese patients with type 2 diabetes: a report from the Swedish national diabetes register
    Eeg-Olofsson, K.
    Gudbjornsdottir, S.
    Eliasson, B.
    Zethelius, B.
    Cederholm, J.
    [J]. DIABETOLOGIA, 2013, 56 : S185 - S186
  • [34] Cardiovascular disease risk stratification in type 2 diabetes
    Esdaile, Harriet
    Mayet, Jamil
    Hill, Neil
    [J]. DIABETIC MEDICINE, 2022, 39 (10)
  • [35] Risk Prediction of Cardiovascular Disease in Type 2 Diabetes
    Cederholm, Jan
    Eeg-Olofsson, Katarina
    Eliasson, Bjoern
    Zethelius, Bjoern
    Nilsson, Peter M.
    Gudbjornsdottir, Soffia
    [J]. DIABETES CARE, 2008, 31 (10) : 2038 - 2043
  • [36] National cardiovascular risk assessment in type 2 diabetes in China
    Hu, D. A. Y. I.
    Ji, L. N.
    Ma, C. S.
    Huo, Y.
    Pan, C. Y.
    Li, G. W.
    Zhuo, H. J.
    Zhang, D.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 884 - 884
  • [37] Multifactorial risk factor control in clinical practice and risk of cardiovascular disease in type 2 diabetes: report from the Swedish national diabetes register
    Eeg-Olofsson, K.
    Gudbjornsdottir, S.
    Eliasson, B.
    Zethelius, B.
    Svensson, A. -M.
    Cederholm, J.
    [J]. DIABETOLOGIA, 2014, 57 : S493 - S493
  • [38] EFFECT OF DIABETES EDUCATION PROGRAM ON TYPE 2 DIABETES
    Younis, M.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A70 - A70
  • [39] Kidney and Type-2 Diabetes Reducing Renal and cardiovascular Risk
    Brettschneider, Helga
    [J]. DIABETES STOFFWECHSEL UND HERZ, 2021, 30 (06): : 411 - 412
  • [40] Cardiovascular risk stratification in patients with type 2 diabetes
    Htoo, Phyo Than T.
    Wexler, Deborah
    Glynn, Robert J.
    Schneeweiss, Sebastian
    Paik, Julie M.
    Patorno, Elisabetta
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 308 - 309